Hepatic responsiveness to gluconeogenic substrates during insulininduced hypoglycemia was investigated. For this purpose, livers were perfused with a saturating concentration of 2 mM glycerol, 5 mM Lalanine or 5 mM L-glutamine as gluconeogenic substrates. All experiments were performed 1 h after an ip injection of saline (CN group) or 1 IU/kg of insulin (IN group). The IN group showed higher (P<0.05) hepatic glucose production from glycerol, L-alanine and L-glutamine and higher (P<0.05) production of L-lactate, pyruvate and urea from L-alanine and L-glutamine. In addition, ip injection of 100 mg/kg glycerol, L-alanine and L-glutamine promoted glucose recovery. The results indicate that the hepatic capacity to produce glucose from gluconeogenic precursors was increased during insulin-induced hypoglycemia.
Introduction
Although insulin inhibits key enzymes of gluconeogenesis (1) and the mobilization of gluconeogenic substrates to the liver (2) (3) (4) (5) , it is well established that insulin-induced hypoglycemia (IIH) provokes the release of hormones (6) (7) (8) (9) (10) (11) , which stimulate hepatic gluconeogenesis (11) (12) (13) (14) (15) (16) .
Although the participation of hepatic gluconeogenesis in glucose recovery has been extensively investigated, relatively little is known about the hepatic responsiveness to gluconeogenic substrates during IIH. Thus, it is not clear whether the higher hepatic glucose production during IIH can be attributed to the improved capacity of the liver to produce glucose and/or to the enhanced availability of gluconeogenic substrates, since the concentration of glucose precursors increases (12, 17, 18) or decreases (8, (19) (20) (21) during IIH, depending on the experimental condition. To clarify this question and to overcome the limitations of in vivo experiments, we employed isolated liver from fasted rats which received a saturating concentration of gluconeogenic substrates at constant flow. This experimental approach eliminates the influence of hepatic glycogen catabolism, changes in hepatic blood flow, and the variability of blood glucose precursors (22) (23) (24) (25) .
Moreover, if the hepatic responsiveness to gluconeogenic substrates is augmented during IIH, the possibility of obtaining glucose recovery by the administration of glucose precursors should be considered. For this reason, we also investigated the effect of the administration of gluconeogenic precursors on glycemia during IIH.
Material and Methods
Male Wistar rats weighing 200 g, aged around 7 weeks and submitted to 6 h of food deprivation were employed.
All experiments were initiated at 2:00 pm to minimize circadian variations. At that time, 1 IU/kg of regular insulin (hypoglycemic rats, IN group) or saline (control rats, CN group) was administered intraperitoneally (ip). Since hypoglycemia has been demonstrated to occur 1 h after insulin administration (23) (24) (25) , this time was selected for all experiments.
Isolated perfused livers were used as described previously (24, 25) . The major advantage of using an isolated organ such as the liver is that the effects measured are attributable directly to the liver and no extrahepatic influence interferes with the results. Even though some techniques remove the liver from the animal, we prefer to leave it in situ. An advantage of leaving the liver in situ is the continuous secretion of bile into the intestine.
Thus, 1 h after the administration of insulin (Neosulin ® , Biobrás, Montes Claros, MG, Brazil) or saline, all rats were anesthetized ip with pentobarbital sodium (40 mg/kg). After laparotomy, blood was collected from the vena cava for the measurement of glucose (26) , glycerol (27) , L-alanine (28) and Lglutamine (29) .
After blood collection, the livers were perfused in situ through the portal vein. Since a proper supply of oxygen is crucial, the liver received a perfusion fluid saturated with oxygen (95% O 2 /5% CO 2 ) at a high flow rate (4 ml/g). The viability of the liver during the perfusion was indicated by the absence of any leaking and/or tissue swelling.
To evaluate the maximal capacity of the liver to produce glucose, L-lactate, pyruvate and urea from saturating concentrations of 2 mM glycerol, 5 mM L-alanine or 5 mM Lglutamine, each substrate was infused between the 10th and 30th min of the perfusion period, followed by a period of post-infusion (20 min) to allow the return to basal levels. Samples of the effluent perfusion fluid were collected at 2-min intervals for a total collection period of 30 min and analyzed for D-glucose, L-lactate, pyruvate and urea. Thus, the maximal hepatic capacity to produce glucose, L-lactate, pyruvate and urea was measured as the difference between the rates of these products released during (10-30 min) and before (0-10 min) substrate infusion. The differences permitted us to obtain and compare the areas under the curves (AUC) for control and hypoglycemic rats.
D-glucose was measured by the glucoseoxidase method (26) . L-Lactate (30) is oxidized to pyruvate by nicotinamide adenine dinucleotide (NAD) in the enzymatic reaction catalyzed by lactate dehydrogenase (LDH). The reduction of NAD is proportional to the substrate converted and is measured spectrophotometrically at 340 nm. Similarly, pyruvate (31) is reduced to L-lactate by NADH in the enzymatic reaction catalyzed by LDH. The oxidation of NADH is proportional to the substrate converted and is measured spectrophotometrically at 340 nm. Additionally, urea (32) was measured using urease. The ammonia resulting from enzymatic hydrolysis of urea reacts with phenol and hypochlorite, producing the blue dye indophenol, which is proportional to urea concentration.
To investigate the effect of the adminis-tration of gluconeogenic substrates on glucose recovery, 100 mg/kg glycerol, 100 mg/ kg L-alanine or 100 mg/kg L-glutamine was injected ip 30 min after insulin administration. In these experiments two control groups which received saline or glucose (100 mg/ kg) were employed. Glycemia was measured in blood samples collected by decapitation 30 min later, i.e., 60 min after insulin injection.
The computer program GraphPad Prism (version 2.0) was used to calculate the AUC, expressed as µmol/g. Statistical analyses were performed using the unpaired Student t-test and the Primer Biostatistics program. A 95% level of confidence (P<0.05) was accepted for all comparisons. Results are reported as means ± SEM.
Results
Insulin administration decreased (P<0.05) the blood concentration of glucose and glycerol. However, blood levels of L-alanine and L-glutamine were similar to those observed in the control animals ( Table 1) .
The maximal hepatic capacity to produce glucose was first evaluated for glycerol. As shown in Figure 1 , the infusion of a saturating concentration of glycerol promoted a rapid increase in hepatic glucose production for both animal groups (IN and CN) . The AUC values calculated by subtracting the basal rates indicated a more intense (P<0.05) activation of glucose production by glycerol for the IN group. Similarly, livers from the IN group showed higher (P<0.05) production of glucose, L-lactate, pyruvate and urea during the infusion of L-alanine ( Figure 2 ) and L-glutamine (Figure 3 ) than the CN group.
Moreover, the effect of ip administration of 100 mg/kg glycerol, 100 mg/kg L-alanine or 100 mg/kg L-glutamine on glycemia during IIH was investigated. As shown in Figure  4 , rats which received an ip injection of glycerol, L-alanine or L-glutamine had higher glycemia (P<0.05) than rats which received saline or glucose.
Discussion
Perfused livers from fasted rats produce negligible amounts of glucose in the absence of gluconeogenic precursors. The addition of glycerol, L-alanine or L-glutamine increases the rate of glucose production in proportion to the amount of the glucose precursor until a saturating concentration is reached (data not shown). Thus, by using a saturating concentration of gluconeogenic precursors it was possible to measure the maximal capacity of the liver to produce glucose from specific substrates (24, 25) .
On the other hand, the most common substrates for gluconeogenesis, such as Llactate and L-alanine, cross the liver cell membrane and are then converted to pyruvate. From the cytosol, pyruvate enters the mitochondria where it is carboxylated and then leaves the mitochondria as aspartate or malate. In the cytosol these compounds are converted to oxaloacetate, then to phosphoenolpyruvate and after various steps they are converted to glucose by microsomal glucose-6-phosphatase and released from the hepatocyte. Since this complex pathway depends on oxygen supply and several cellular compartments (plasma membrane, cytosol, mitochondria and microsomal fraction), the production of glucose, L-lactate and pyruvate from L-alanine can be used as a marker of the integrity of this metabolic pathway. An absence of glucose production and/or a high L-lactate/pyruvate ratio indicate low viability and/or poor oxygenation. Thus, Lalanine works as a good marker of the quality of the organ preparation. Therefore, by using a saturating concentration of 2 mM glycerol, 5 mM L-alanine or 5 mM L-glutamine we obtained data compatible with the view that the ability of the liver to produce glucose increases during IIH. This conclusion is based on the observation that livers from hypoglycemic rats show higher glucose production from glycerol (Figure 1) , L-alanine ( Figure 2A ) and L-glutamine ( Figure 3A) . Part of these results can be explained by the fact that there is an increased release of counterregulatory hormones during IIH (6-10) which antagonize the effects of insulin on the gluconeogenesis key enzymes (1,33), i.e., pyruvate kinase and phosphoenolpyruvate carboxykinase. However, the participation of these enzymes is not the whole story since substrates that enter the gluconeogenic pathway at the triose phosphate step (glycerol) were similarly affected by IIH. The higher hepatic glucose production from L-alanine exhibited by the IN group was probably the result of the increased catabolism of this amino acid, inferred by the higher (P<0.05) urea production ( Figure  2D ) which favored the generation of gluconeogenic intermediaries in the liver. In agreement with this observation, the IN group showed higher (P<0.05) hepatic production of L-lactate ( Figure 2B ) and pyruvate (Figure 2C ) during L-alanine infusion. Consequently, the increased availability of L-lactate and pyruvate in the hepatocyte favored gluconeogenesis (34, 35) and helped to explain the higher hepatic glucose production showed by the IN group during the L-alanine infusion (Figure 2A) .
Livers from the IN group also showed higher (P<0.05) hepatic production of Llactate, pyruvate and urea from L-glutamine (Figure 3) . The higher production of urea ( Figure 3D , P<0.05) was probably due to the increased catabolism of L-glutamine, which contributed to the higher capacity of glucose production. On the other hand, since L-glutamine is not a precursor of pyruvate or L- lactate directly and because the kinetics and magnitude of L-lactate and pyruvate production followed the kinetics of glucose production ( Figure 3A) , it is possible that the pyruvate and L-lactate produced during L-glutamine infusion came from glycolysis. In addition, we observed a delay in the conversion of L-glutamine to glucose, pyruvate, L-lactate and urea (Figure 3 ), an effect that may be attributed to the slow activation of hepatic glutaminase (36, 37) . Since during IIH, blood glucose precursors investigated were decreased or maintained (Table 1 ) and the hepatic capacity to produce glucose from these substrates was increased (Figures 1, 2, and 3) , we determined whether the ip injection of these precursors (glycerol, L-alanine and L-glutamine, each 100 mg/kg) could promote glucose recovery.
As illustrated in Figure 4 , rats that received glycerol, L-alanine or L-glutamine 30 min after insulin administration showed higher (P<0.05) glycemia than the controls. Moreover, the absence of glycemia recovery during glucose administration, in contrast to gluconeogenic substrate injection, was unexpected.
Thus, we conclude that the administration of gluconeogenic precursors during IIH promoted glucose recovery due to the increased hepatic responsiveness to gluconeogenic substrates. Finally, our previous results (24, 25) , taken together with those of the present study, suggest the possibility of the administration of glucose precursors for the treatment of IIH, particularly in conditions in which therapy with glucagon is not effective. Figure 4 . Effect of saline (C), glucose (Gl), glycerol (G), L-alanine (A) and L-glutamine (Gt) on glycemia. All substances (100 mg/ kg, ip) were administered 30 min after insulin injection and glycemia was measured 60 min after insulin administration. Data are reported as means ± SEM of 7-9 rats. *P<0.05 vs C group (unpaired Student t-test). * * *
